Bill C-11 (Historical)

Human Pathogens and Toxins Act

An Act to promote safety and security with respect to human pathogens and toxins

This bill was last introduced in the 40th Parliament, 2nd Session, which ended in December 2009.

Sponsor

Leona Aglukkaq  Conservative

Status

This bill has received Royal Assent and is now law.

Summary

This is from the published bill.

This enactment creates measures to promote safety and security with respect to human pathogens and toxins and all activities associated with them. It establishes a comprehensive legislative regime that extends beyond the present importation regime. It requires every person conducting activities involving human pathogens or toxins to take all reasonable measures to protect the health and safety of the public.

Elsewhere

All sorts of information on this bill is available at LEGISinfo, an excellent resource from the Library of Parliament. You can also read the full text of the bill.

Votes

May 5, 2009 Passed That the Bill be now read a third time and do pass.
April 27, 2009 Passed That Bill C-11, An Act to promote safety and security with respect to human pathogens and toxins, {as amended}, be concurred in at report stage [with a further amendment/with further amendments] .

Health Committee, on March 3, 2009

  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada
  • James Gilbert, Director General, Strategic Policy Directorate, Public Health Agency of Canada
  • Frank Plummer, Scientific Director General, National Microbiology Laboratory, Public Health Agency of Canada

Health Committee, on March 5, 2009

  • Peter Singer, Director and Professor of Medicine, University Health Network and University of Toronto, McLaughlin-Rotman Centre for Global Health
  • Marc Ouellette, Professor, Laval University
  • Greg Matlashewski, Professor, Department of Microbiology and Immunology, McGill University
  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada
  • James Gilbert, Director General, Strategic Policy Directorate, Public Health Agency of Canada
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada
  • Frank Plummer, Scientific Director General, National Microbiology Laboratory, Public Health Agency of Canada

Health Committee, on March 10, 2009

  • Alicia Sarabia, Section Head, Medical Microbiology, The Credit Valley Hospital, Association of Medical Microbiology and Infectious Disease Canada
  • Vivek Goel, President and Chief Executive Officer, Ontario Agency for Health Protection and Promotion
  • Michael Hynes, Professor, Department of Biological Sciences, University of Calgary
  • Albert Descoteaux, Professor, Institut Armand-Frappier, Institut national de la recherche scientifique
  • Don Low, Medical Director, Public Health Laboratories, Ontario Agency for Health Protection and Promotion

Health Committee, on March 12, 2009

  • Ayoob Ghalami, Senior Biosafety Officer, Environmental Health and Safety, University of Toronto
  • Wayne Conlan, Principal Research Officer, National Research Council, As an Individual
  • David Butler-Jones, Chief Public Health Officer, Public Health Agency of Canada
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada
  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada

Health Committee, on March 24, 2009

  • Elaine Gibson, Professor and Associate Director, Health Law Institute, As an Individual
  • Roland Leitner, Occupational Health and Safety Consultant, As an Individual
  • Raymond Tellier, Medical Microbiologist, Associate Professor, As an Individual
  • David Butler-Jones, Chief Public Health Officer, Public Health Agency of Canada
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada
  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada

Health Committee, on March 26, 2009

  • David Butler-Jones, Chief Public Health Officer, Public Health Agency of Canada
  • Albert Descoteaux, Professor, Institut Armand-Frappier, Institut national de la recherche scientifique
  • Marc Ouellette, Professor, Laval University
  • Greg Matlashewski, Department of Microbiology and Immunology, McGill University
  • Peter Singer, Director and Professor of Medicine, University Health Network and University of Toronto, McLaughlin-Rotman Centre for Global Health
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada
  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada

Health Committee, on March 31, 2009

  • Theresa Tam, Director General, Centre for Emergency Preparedness and Response, Infectious Disease and Emergency Preparedness Branch, Public Health Agency of Canada
  • Jane Allain, General Counsel, Legal Services, Public Health Agency of Canada